HR Execs on the Move

ScotiaCare

www.scotiacare.com

 
ScotiaCare is a Dartmouth, NS-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Booth Radiology Assoc

Since 1948, Booth Radiology has been providing physicians and patients of Gloucester County with superior diagnostic imaging services at our two full-service locations in Washington Township and Woodbury, NJ. Booth Radiology now proudly offers service in

Forrest Hill Healthcare Center

Forrest Hill Healthcare Center is a Newark, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SALMON Health and Retirement

SALMON Health and Retirement is a Natick, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Colorado Nurse

Colorado Nurse is a Denver, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ChenMed

ChenMed brings concierge-style medicine and better health outcomes to the neediest populations – moderate-to-low income seniors with complex chronic diseases. Operating over 50 medical centers in eight states, we are known to our patients as Dedicated Senior Medical Center, Chen Senior Medical Center, or JenCare Senior Medical Center. Through our innovative operating model, physician-led culture and empowering technology, we drive key quality and cost outcomes that create value for patients, physicians and the overall health system. By recruiting focused physicians and reducing their doctor-to-patient ratios, we increase patients` “face time” during each monthly appointment and help foster stronger doctor-patient relationships. Results of our high-touch approach to primary care are impressive, as illustrated in the recent Modern Healthcare cover story published on Oct. 20, 2018, which reports that: “Indeed, ChenMed`s approach has resulted in 50 percent fewer hospital admissions compared with a standard primary-care practice, 28 percent lower per-member costs, and significantly higher use of evidence-based medications.”